Umoja Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Umoja Biopharma's estimated annual revenue is currently $47.2M per year.
- Umoja Biopharma's estimated revenue per employee is $201,000
- Umoja Biopharma's total funding is $371M.
Employee Data
- Umoja Biopharma has 235 Employees.
- Umoja Biopharma grew their employee count by -5% last year.
Umoja Biopharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder & CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Co-founder and CTO | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Chief Legal Officer | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | Chief Staff & Head Administration | Reveal Email/Phone |
9 | Chief Legal Officer | Reveal Email/Phone |
10 | Chief Medical Officer | Reveal Email/Phone |
Umoja Biopharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $23.3M | 116 | 33% | N/A | N/A |
#2 | $0.8M | 8 | -53% | N/A | N/A |
#3 | $130M | 647 | 14% | N/A | N/A |
#4 | $23.3M | 116 | 13% | N/A | N/A |
#5 | $6.6M | 33 | 18% | N/A | N/A |
#6 | $10.1M | 50 | -43% | N/A | N/A |
#7 | $13.5M | 67 | -3% | N/A | N/A |
#8 | $4.4M | 22 | -19% | N/A | N/A |
#9 | $0.8M | 8 | 0% | $22M | N/A |
#10 | $5.6M | 28 | 4% | N/A | N/A |
What Is Umoja Biopharma?
Umoja is developing a new approach to cancer therapy that retools a patient's immune system in vivo, enhancing the body's natural capacity to fight cancer. We envision a world where all patients with cancer have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.
keywords:N/A
$371M
Total Funding
235
Number of Employees
$47.2M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Umoja Biopharma News
2022-04-06 - Umoja Biopharma Presents Data on its iPSC-Based Cell ...
Umoja Biopharma Presents Data on its iPSC-Based Cell Therapy Platform at the American Association for Cancer Research (AACR) Annual Meeting...
2022-03-22 - Fred Hutch spinout Affini-T Therapeutics lands $175M for cell therapies to
treat solid tumors
Seattle biotech clout: Affini-T joins the ranks of cell therapy companies ... Umoja Biopharma recently raised $263 million in Series A and B...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $69.8M | 235 | 0% | N/A |
#2 | $54.5M | 236 | 1% | N/A |
#3 | $15M | 236 | 19% | N/A |
#4 | $70.4M | 237 | 0% | N/A |
#5 | $36M | 239 | 3% | $18M |